Connor, Clark & Lunn Investment Management (CC&L)’s XBiotech XBIT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
48,274
-16,911
| -26% | -$50.2K | ﹤0.01% | 1441 |
|
|
2025
Q1 | $211K | Sell |
65,185
-9,009
| -12% | -$29.2K | ﹤0.01% | 1324 |
|
|
2024
Q4 | $293K | Sell |
74,194
-1,521
| -2% | -$6.01K | ﹤0.01% | 1263 |
|
|
2024
Q3 | $585K | Sell |
75,715
-2,008
| -3% | -$15.5K | ﹤0.01% | 1057 |
|
|
2024
Q2 | $399K | Buy |
77,723
+310
| +0.4% | +$1.59K | ﹤0.01% | 1109 |
|
|
2024
Q1 | $629K | Buy |
77,413
+13,468
| +21% | +$109K | ﹤0.01% | 1040 |
|
|
2023
Q4 | $256K | Sell |
63,945
-373
| -0.6% | -$1.49K | ﹤0.01% | 1210 |
|
|
2023
Q3 | $265K | Buy |
64,318
+24
| +0% | +$99 | ﹤0.01% | 1174 |
|
|
2023
Q2 | $382K | Buy |
64,294
+6,378
| +11% | +$37.9K | ﹤0.01% | 1050 |
|
|
2023
Q1 | $200K | Sell |
57,916
-7,110
| -11% | -$24.5K | ﹤0.01% | 1100 |
|
|
2022
Q4 | $228K | Sell |
65,026
-2,949
| -4% | -$10.4K | ﹤0.01% | 1033 |
|
|
2022
Q3 | $246K | Buy |
67,975
+18,863
| +38% | +$68.3K | ﹤0.01% | 959 |
|
|
2022
Q2 | $277K | Buy |
49,112
+25,509
| +108% | +$144K | ﹤0.01% | 878 |
|
|
2022
Q1 | $204K | Buy |
+23,603
| New | +$204K | ﹤0.01% | 942 |
|